LEADRY
US trademark, USPTO serial 99835749
"LEADRY" is a registered US trademark filing (serial 99835749), owned by Eli Lilly and Company, filed May 20, 2026.
Get an email when this status changes
We email you about office actions, publication and registration for free, and we check after each USPTO data update.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Filing details
| Status | Registered |
| Serial number | 99835749 |
| Filing date | May 20, 2026 |
| Owner | Eli Lilly and Company (379 filings) |
| NICE classes | Class 5 |
Goods and services
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, retinal disease, rheumatoid arthritis, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management
Source and method
Built from public USPTO trademark records via WikiTrademarks. We match by exact wording, whole-word, phonetic sound-alike, and fuzzy look-alike, scoped by NICE class. Data reflects the most recent USPTO import. Last updated November 19, 2026.
Cite this page: WikiTrademarks, "LEADRY trademark (serial 99835749)", https://wikitrademarks.com/trademark/99835749/leadry (accessed November 19, 2026).